Flamingo Therapeutics Announces Appointment of Andrew E. Denker, MD, PhD, as Chief Medical Officer
/PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today announced the appointment of Andrew E. Denker, MD, PhD., as Chief Medical Officer. Dr. Denker is a...
Region Flamande United States Thomas Jefferson University Andrewe Denker Stephane Van Rooijen Amy Conrad
Source: prnewswire.com